ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351909. A total of 5 filers reported holding ALEXION PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,449,000 | -4.7% | 20,200 | -3.8% | 0.02% | +50.0% |
| Q4 2016 | $2,569,000 | -41.1% | 21,000 | -41.0% | 0.01% | -42.9% |
| Q3 2016 | $4,362,000 | -58.1% | 35,600 | -60.1% | 0.02% | -57.1% |
| Q2 2016 | $10,415,000 | +33.8% | 89,200 | +59.6% | 0.05% | +32.4% |
| Q1 2016 | $7,782,000 | +6.5% | 55,900 | +46.0% | 0.04% | +2.8% |
| Q4 2015 | $7,306,000 | -21.2% | 38,300 | -35.4% | 0.04% | -5.3% |
| Q3 2015 | $9,274,000 | -37.4% | 59,300 | -27.7% | 0.04% | -43.3% |
| Q2 2015 | $14,823,000 | +30.0% | 82,000 | +24.6% | 0.07% | +31.4% |
| Q1 2015 | $11,403,000 | -8.4% | 65,800 | -2.2% | 0.05% | +2.0% |
| Q4 2014 | $12,453,000 | +45.5% | 67,300 | +30.4% | 0.05% | +42.9% |
| Q3 2014 | $8,556,000 | +27.3% | 51,600 | +20.0% | 0.04% | +16.7% |
| Q2 2014 | $6,719,000 | -34.5% | 43,000 | -36.2% | 0.03% | -30.2% |
| Q1 2014 | $10,254,000 | +69.2% | 67,400 | +47.8% | 0.04% | +95.5% |
| Q4 2013 | $6,060,000 | +10.5% | 45,600 | -3.4% | 0.02% | +15.8% |
| Q3 2013 | $5,483,000 | -4.9% | 47,200 | -24.5% | 0.02% | -9.5% |
| Q2 2013 | $5,765,000 | – | 62,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|